ID CASK_BOVIN Reviewed; 190 AA. AC P02668; O46566; Q597F3; Q6U205; Q9N271; Q9TRQ3; Q9TV96; Q9TV97; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1988, sequence version 1. DT 08-NOV-2023, entry version 167. DE RecName: Full=Kappa-casein; DE Contains: DE RecName: Full=Casoxin-C; DE Contains: DE RecName: Full=Casoxin-6; DE Contains: DE RecName: Full=Casoxin-A; DE Contains: DE RecName: Full=Casoxin-B; DE Contains: DE RecName: Full=Casoplatelin; DE Flags: Precursor; GN Name=CSN3; Synonyms=CSN10, CSNK; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (VARIANT A). RX PubMed=6328443; DOI=10.1093/nar/12.9.3895; RA Stewart A.F., Willis I.M., Mackinlay A.G.; RT "Nucleotide sequences of bovine alpha S1- and kappa-casein cDNAs."; RL Nucleic Acids Res. 12:3895-3907(1984). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (VARIANT B2). RX PubMed=3582972; RA Gorodetskii S.I., Kaledin A.S.; RT "Nucleotide sequence of the cDNA of kappa casein in cows."; RL Genetika 23:596-604(1987). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANT A). RX PubMed=3208764; DOI=10.1111/j.1432-1033.1988.tb14463.x; RA Alexander L.J., Stewart A.F., McKinlay A.G., Kapelinskaya T.V., Tkach T.M., RA Gorodetsky S.I.; RT "Isolation and characterization of the bovine kappa-casein gene."; RL Eur. J. Biochem. 178:395-401(1988). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANTS A AND B). RC TISSUE=Blood; RX PubMed=15771744; DOI=10.1111/j.1365-2052.2005.01260.x; RA Robitaille G., Britten M., Morisset J., Petitclerc D.; RT "Polymorphism in the bovine kappa-casein (CSN3) gene and the 5'-flanking RT region: sequence analysis of CSN3 A and B alleles."; RL Anim. Genet. 36:184-185(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (VARIANT B). RC STRAIN=Hereford; TISSUE=Mammary gland; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP PROTEIN SEQUENCE OF 22-127 (VARIANT B). RX PubMed=4577852; DOI=10.1111/j.1432-1033.1973.tb02829.x; RA Mercier J.-C., Brignon G., Ribadeau-Dumas B.; RT "Primary structure of bovine kappa B casein. Complete sequence."; RL Eur. J. Biochem. 35:222-235(1973). RN [7] RP PROTEIN SEQUENCE OF 22-126 (VARIANT A). RA Jolles J., Schoentgen F., Alais C., Jolles P.; RT "Studies on the primary structure of cow kappa-casein. The primary sequence RT of cow para-kappa-casein."; RL Chimia 26:645-646(1972). RN [8] RP PROTEIN SEQUENCE OF 22-38 AND 97-116, PYROGLUTAMATE FORMATION AT GLN-22, RP INTERCHAIN DISULFIDE BONDS, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=1628650; DOI=10.1111/j.1432-1033.1992.tb17040.x; RA Rasmussen L.K., Hoejrup P., Petersen T.E.; RT "The multimeric structure and disulfide-bonding pattern of bovine kappa- RT casein."; RL Eur. J. Biochem. 207:215-222(1992). RN [9] RP NUCLEOTIDE SEQUENCE [MRNA] OF 31-45. RX PubMed=6897774; DOI=10.1089/dna.1982.1.375; RA Willis I.M., Stewart A.F., Caputo A., Thompson A.R., McKinlay A.G.; RT "Construction and identification by partial nucleotide sequence analysis of RT bovine casein and beta-lactoglobulin cDNA clones."; RL DNA 1:375-386(1982). RN [10] RP NUCLEOTIDE SEQUENCE OF 31-190 (VARIANTS F AND G). RC STRAIN=Ayrshire, and Pinzgauer; RX PubMed=8930077; DOI=10.1111/j.1365-2052.1996.tb00976.x; RA Prinzenberg E.M., Hiendleder S., Ikonen T., Erhardt G.; RT "Molecular genetic characterization of new bovine kappa-casein alleles RT CSN3F and CSN3G and genotyping by PCR-RFLP."; RL Anim. Genet. 27:347-349(1996). RN [11] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-190 (VARIANT H). RC STRAIN=Pinzgauer; RX PubMed=10654430; DOI=10.1080/10495399909525921; RA Prinzenberg E.M., Krause I., Erhardt G.; RT "SSCP analysis at the bovine CSN3 locus discriminates six alleles RT corresponding to known protein variants (A, B, C, E, F, G) and three new RT DNA polymorphisms (H, I, A1)."; RL Anim. Biotechnol. 10:49-62(1999). RN [12] RP PROTEIN SEQUENCE OF 54-59. RX PubMed=8161175; DOI=10.1128/aem.60.3.801-806.1994; RA Reid J.R., Coolbear T., Pillidge C.J., Pritchard G.G.; RT "Specificity of hydrolysis of bovine kappa-casein by cell envelope- RT associated proteinases from Lactococcus lactis strains."; RL Appl. Environ. Microbiol. 60:801-806(1994). RN [13] RP NUCLEOTIDE SEQUENCE [MRNA] OF 92-190 (VARIANT B2). RX PubMed=6689612; RA Gorodetskii S.I., Kershulyte D.R., Korobko V.G.; RT "Primary structure of cDNA of Bos taurus kappa-casein macropeptide."; RL Bioorg. Khim. 9:1693-1695(1983). RN [14] RP PARTIAL PROTEIN SEQUENCE (VARIANT A). RX PubMed=4653404; DOI=10.1002/hlca.19720550820; RA Jolles J., Schoentgen F., Alais C., Fiat A.-M., Jolles P.; RT "Studies on the primary structure of cow kappa-casein. Structural features RT of para-kappa-casein; N-terminal sequence of kappa-caseinoglycopeptide RT studied with a sequencer."; RL Helv. Chim. Acta 55:2872-2883(1972). RN [15] RP PROTEIN SEQUENCE OF 127-168 AND 187-190. RC TISSUE=Colostrum; RX PubMed=4407313; DOI=10.1016/0005-2795(74)90195-0; RA Guerin J., Alais C., Jolles J., Jolles P.; RT "Kappa-casein from bovine colostrum."; RL Biochim. Biophys. Acta 351:325-332(1974). RN [16] RP PROTEIN SEQUENCE OF 128-190 (VARIANTS A AND B). RA Grosclaude F., Mahe M.-F., Mercier J.-C., Ribadeau-Dumas B.; RT "Localization of amino-acid substitutions that differenciate bovine kappa- RT casein variants A and B."; RL Ann. Genet. Sel. Anim. 4:515-521(1972). RN [17] RP NUCLEOTIDE SEQUENCE OF 133-190 (VARIANT E). RX PubMed=1683188; DOI=10.1111/j.1365-2052.1991.tb00687.x; RA Schlieben S., Erhardt G., Senft B.; RT "Genotyping of bovine kappa-casein (kappa-CNA, kappa-CNB, kappa-CNC, kappa- RT CNE) following DNA sequence amplification and direct sequencing of kappa- RT CNE PCR product."; RL Anim. Genet. 22:333-342(1991). RN [18] RP NUCLEOTIDE SEQUENCE OF 133-190 (VARIANTS A AND B). RA Woollard J.R., Dentine M.R.; RL Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases. RN [19] RP GLYCOSYLATION AT THR-142; THR-152; THR-154; THR-157; THR-163 AND THR-186. RX PubMed=7734846; DOI=10.1093/glycob/4.6.837; RA Pisano A., Packer N.H., Redmond J.W., Williams K.L., Gooley A.A.; RT "Characterization of O-linked glycosylation motifs in the glycopeptide RT domain of bovine kappa-casein."; RL Glycobiology 4:837-844(1994). RN [20] RP GLYCOSYLATION AT THR-142; THR-152; THR-154; THR-157; THR-163 AND THR-186, RP AND PHOSPHORYLATION AT SER-148 AND SER-170. RX PubMed=8817876; DOI=10.1016/0021-9673(96)00122-7; RA Minkiewicz P., Slangen C.J., Lagerwerf F.M., Haverkamp J., Rollema H.S., RA Visser S.; RT "Reversed-phase high-performance liquid chromatographic separation of RT bovine kappa-casein macropeptide and characterization of isolated RT fractions."; RL J. Chromatogr. A 743:123-135(1996). RN [21] RP ACTIVITY OF CASOXINS. RX PubMed=2760302; DOI=10.1017/s0022029900028818; RA Chiba H., Tani F., Yoshikawa M.; RT "Opioid antagonist peptides derived from kappa-casein."; RL J. Dairy Res. 56:363-366(1989). RN [22] RP ACTIVITY OF CASOPLATELIN. RX PubMed=3732274; DOI=10.1111/j.1432-1033.1986.tb09764.x; RA Jolles P., Levy-Toledano S., Fiat A.-M., Soria C., Gillessen D., RA Thomaidis A., Dunn F.W., Caen J.P.; RT "Analogy between fibrinogen and casein. Effect of an undecapeptide isolated RT from kappa-casein on platelet function."; RL Eur. J. Biochem. 158:379-382(1986). RN [23] RP GLYCOSYLATION AT THR-142; THR-152; SER-153; THR-154; THR-157; THR-163; RP SER-170 AND THR-186, PHOSPHORYLATION AT THR-166 AND SER-170, AND RP IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=25456591; DOI=10.1016/j.chroma.2014.10.046; RA Huang L.J., Lin J.H., Tsai J.H., Chu Y.Y., Chen Y.W., Chen S.L., Chen S.H.; RT "Identification of protein O-glycosylation site and corresponding glycans RT using liquid chromatography-tandem mass spectrometry via mapping accurate RT mass and retention time shift."; RL J. Chromatogr. A 1371:136-145(2014). CC -!- FUNCTION: Kappa-casein stabilizes micelle formation, preventing casein CC precipitation in milk. CC -!- FUNCTION: Casoxins A, B and C have opioid antagonist activity. Casoxin CC C causes biphasic ileal contractions through the binding to the CC complement C3a receptors. CC -!- FUNCTION: Casoplatelin inhibits platelet aggregation. CC -!- SUBUNIT: Monomer or homomultimer; disulfide-linked. CC -!- INTERACTION: CC P02668; P02668: CSN3; NbExp=2; IntAct=EBI-7234047, EBI-7234047; CC P02668; Q9RA63: clpB; Xeno; NbExp=3; IntAct=EBI-7234047, EBI-7698530; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Mammary gland specific. Secreted in milk. CC -!- MISCELLANEOUS: The sequence shown is the A variant. CC -!- SIMILARITY: Belongs to the kappa-casein family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Protein Spotlight; Note=Of buttons, digestion and CC glue - Issue 16 of November 2001; CC URL="https://web.expasy.org/spotlight/back_issues/016"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X00565; CAA25231.1; -; mRNA. DR EMBL; M36641; AAA30433.1; -; mRNA. DR EMBL; X14907; CAA33034.1; -; Genomic_DNA. DR EMBL; X14908; CAA33034.1; JOINED; Genomic_DNA. DR EMBL; AY380228; AAQ87922.1; -; Genomic_DNA. DR EMBL; AY380229; AAQ87923.1; -; Genomic_DNA. DR EMBL; BC102120; AAI02121.1; -; mRNA. DR EMBL; K01085; AAA30482.1; -; mRNA. DR EMBL; AF123250; AAD32139.1; -; Genomic_DNA. DR EMBL; AF123251; AAD32140.1; -; Genomic_DNA. DR EMBL; AF105260; AAF72097.1; -; Genomic_DNA. DR EMBL; M38333; AAA30432.1; -; mRNA. DR EMBL; AF041482; AAB97519.1; -; Genomic_DNA. DR EMBL; U84250; AAB47260.1; -; Genomic_DNA. DR EMBL; U84251; AAB47261.1; -; Genomic_DNA. DR PIR; S02076; KKBOB. DR RefSeq; NP_776719.1; NM_174294.2. DR AlphaFoldDB; P02668; -. DR BioGRID; 159044; 3. DR IntAct; P02668; 1. DR MINT; P02668; -. DR STRING; 9913.ENSBTAP00000028685; -. DR Allergome; 10200; Bos d 12.0101. DR Allergome; 167; Bos d 8. DR Allergome; 2737; Bos d 12. DR CarbonylDB; P02668; -. DR GlyConnect; 309; 19 O-Linked glycans (7 sites). DR GlyCosmos; P02668; 8 sites, 20 glycans. DR iPTMnet; P02668; -. DR PaxDb; 9913-ENSBTAP00000028685; -. DR PeptideAtlas; P02668; -. DR GeneID; 281728; -. DR KEGG; bta:281728; -. DR CTD; 1448; -. DR eggNOG; ENOG502TM2T; Eukaryota. DR HOGENOM; CLU_103388_0_0_1; -. DR InParanoid; P02668; -. DR OrthoDB; 5265313at2759; -. DR TreeFam; TF338369; -. DR Proteomes; UP000009136; Unplaced. DR GO; GO:0005615; C:extracellular space; IDA:AgBase. DR GO; GO:0005794; C:Golgi apparatus; IDA:AgBase. DR GO; GO:0005796; C:Golgi lumen; IDA:AgBase. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0035375; F:zymogen binding; IPI:AgBase. DR GO; GO:0007595; P:lactation; IBA:GO_Central. DR GO; GO:0050821; P:protein stabilization; IBA:GO_Central. DR GO; GO:1903496; P:response to 11-deoxycorticosterone; IDA:AgBase. DR GO; GO:1903494; P:response to dehydroepiandrosterone; IDA:AgBase. DR GO; GO:0032355; P:response to estradiol; IDA:AgBase. DR GO; GO:0032570; P:response to progesterone; IDA:AgBase. DR InterPro; IPR000117; Casein_kappa. DR PANTHER; PTHR11470; KAPPA CASEIN; 1. DR PANTHER; PTHR11470:SF2; KAPPA-CASEIN; 1. DR Pfam; PF00997; Casein_kappa; 1. DR PIRSF; PIRSF002374; Casein_kappa; 1. PE 1: Evidence at protein level; KW Direct protein sequencing; Disulfide bond; Glycoprotein; Milk protein; KW Phosphoprotein; Pyrrolidone carboxylic acid; Reference proteome; Secreted; KW Signal. FT SIGNAL 1..21 FT /evidence="ECO:0000269|PubMed:1628650, FT ECO:0000269|PubMed:4577852, ECO:0000269|Ref.7" FT CHAIN 22..190 FT /note="Kappa-casein" FT /id="PRO_0000004483" FT PEPTIDE 46..55 FT /note="Casoxin-C" FT /id="PRO_0000004484" FT PEPTIDE 54..59 FT /note="Casoxin-6" FT /id="PRO_0000004485" FT PEPTIDE 56..62 FT /note="Casoxin-A" FT /id="PRO_0000004486" FT PEPTIDE 79..82 FT /note="Casoxin-B" FT /id="PRO_0000004487" FT PEPTIDE 127..137 FT /note="Casoplatelin" FT /id="PRO_0000004488" FT SITE 126..127 FT /note="Cleavage; by chymosin/rennin" FT MOD_RES 22 FT /note="Pyrrolidone carboxylic acid" FT /evidence="ECO:0000269|PubMed:1628650" FT MOD_RES 148 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:8817876" FT MOD_RES 166 FT /note="Phosphothreonine" FT /evidence="ECO:0000269|PubMed:25456591" FT MOD_RES 170 FT /note="Phosphoserine; alternate" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:8817876" FT MOD_RES 187 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P02670" FT CARBOHYD 142 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT CARBOHYD 152 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT CARBOHYD 153 FT /note="O-linked (GalNAc...) serine" FT /evidence="ECO:0000269|PubMed:25456591" FT CARBOHYD 154 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT CARBOHYD 157 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT CARBOHYD 163 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT CARBOHYD 170 FT /note="O-linked (GalNAc...) serine; alternate" FT /evidence="ECO:0000269|PubMed:25456591" FT CARBOHYD 186 FT /note="O-linked (GalNAc...) threonine; partial" FT /evidence="ECO:0000269|PubMed:25456591, FT ECO:0000269|PubMed:7734846, ECO:0000269|PubMed:8817876" FT DISULFID 32..109 FT DISULFID 32 FT /note="Interchain (with C-109); in linked form" FT DISULFID 109 FT /note="Interchain (with C-32); in linked form" FT VARIANT 31 FT /note="R -> H (in variant F)" FT VARIANT 118 FT /note="R -> C (in variant G)" FT VARIANT 156 FT /note="T -> I (in variant G and variant H)" FT VARIANT 157 FT /note="T -> I (in variant B and variant B2)" FT VARIANT 169 FT /note="D -> A (in variant B and variant B2)" FT VARIANT 174 FT /note="I -> T (in variant B2)" FT VARIANT 176 FT /note="S -> G (in variant E)" FT CONFLICT 23 FT /note="E -> Q (in Ref. 7; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 26 FT /note="Q -> E (in Ref. 7; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 28 FT /note="Q -> E (in Ref. 7; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 102 FT /note="N -> D (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 190 AA; 21269 MW; F12D8310C3B93EDA CRC64; MMKSFFLVVT ILALTLPFLG AQEQNQEQPI RCEKDERFFS DKIAKYIPIQ YVLSRYPSYG LNYYQQKPVA LINNQFLPYP YYAKPAAVRS PAQILQWQVL SNTVPAKSCQ AQPTTMARHP HPHLSFMAIP PKKNQDKTEI PTINTIASGE PTSTPTTEAV ESTVATLEDS PEVIESPPEI NTVQVTSTAV //